Intravesical therapy of bladder cancer: an immunotherapy success story.
Morales
A
A
Department of Urology, Queen's University, Kingston, Ontario, Canada.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001500:BCG Vaccine / Q000627:therapeutic use; D002278:Carcinoma in Situ / Q000473:pathology / Q000628:therapy*; D002295:Carcinoma, Transitional Cell / Q000473:pathology / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D007372:Interferons / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D016896:Treatment Outcome; D001749:Urinary Bladder Neoplasms / Q000473:pathology / Q000628:therapy*
D000970:Antineoplastic Agents; D001500:BCG Vaccine; D007372:Interferons